These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11789127)

  • 1. [Alzheimer patients treated with anti-dementia drugs despite unanswered questions].
    Padberg F; Hampel H; Möller HJ
    Fortschr Med Orig; 2001 Nov; 119(3-4):141-3. PubMed ID: 11789127
    [No Abstract]   [Full Text] [Related]  

  • 2. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.
    Kurz A; Van Baelen B
    Dement Geriatr Cogn Disord; 2004; 18(2):217-26. PubMed ID: 15237280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative care--can ginkgo improve cognitive function?
    Eliopoulos C
    Director; 2005; 13(1):44-5. PubMed ID: 17715873
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
    Gasser US; Gasser T
    MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
    [No Abstract]   [Full Text] [Related]  

  • 5. Featured CME topic: dementia. Medication update.
    Slagle MA
    South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antidementia drugs].
    Müller-Spahn F; Sollberger D; Wollmer MA
    Ther Umsch; 2009 Jun; 66(6):432-40. PubMed ID: 19496039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for Alzheimer's disease.
    Wilcock GK
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract]   [Full Text] [Related]  

  • 8. [A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia].
    Schreiter Gasser U; Gasser T
    Fortschr Med Orig; 2001 Nov; 119(3-4):135-8. PubMed ID: 11789125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cholinesterase inhibitor and ginkgo extracts in therapy of dementia. A comparison of effectiveness based on controlled studies].
    Wettstein A
    Fortschr Med; 1999 Feb; 117(5):48-9. PubMed ID: 10095316
    [No Abstract]   [Full Text] [Related]  

  • 12. [Consensus statement "Dementia 2010" of the Austrian Alzheimer Society].
    Schmidt R; Marksteiner M; Dal-Bianco P; Ransmayr G; Bancher C; Benke T; Wancata J; Fischer P; Leblhuber CF; Psota G; Ackerl M; Alf C; Berek K; Croy A; Delazer M; Fasching P; Frühwald T; Fruhwürth G; Fuchs-Nieder B; Gatterer G; Grossmann J; Hinterhuber H; Iglseder B; Imarhiagbe D; Jagsch C; Jellinger K; Kalousek M; Kapeller P; Ladurner G; Lampl C; Lechner A; Lingg A; Nakajima T; Rainer M; Reisecker F; Spatt J; Walch T; Uranüs M; Walter A
    Neuropsychiatr; 2010; 24(2):67-87. PubMed ID: 20605003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM; Farlow MR
    Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rational therapy of Alzheimer dementia based on current clinical studies].
    Zöller B; Hock C; Kull HU
    Praxis (Bern 1994); 2001 May; 90(19):827-34. PubMed ID: 11407240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiac effects of cholinesterase inhibitors: a reason for restraint?].
    Salarbaks AM; Boomkamp-Snoeren CM; van Puijenbroek E; Jansen PA; van Marum RJ
    Tijdschr Gerontol Geriatr; 2009 Apr; 40(2):79-84. PubMed ID: 19472574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alzheimer's disease therapy--theory and practice].
    Gabryelewicz T; Barcikowska M; Jarczewska DL
    Wiad Lek; 2005; 58(9-10):528-35. PubMed ID: 16529064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Final IQWiG to Ginkgo biloba].
    Winckler T
    Pharm Unserer Zeit; 2009; 38(5):454-61. PubMed ID: 19711323
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholinesterase inhibitors. Comparing the options for mild-to-moderate dementia.
    Conn DK;
    Geriatrics; 2001 Sep; 56(9):56-7. PubMed ID: 11582975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.